Published in Scand J Haematol on February 01, 1980
Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet (1978) 3.74
Abnormal diurnal rhythm of urine output following renal transplantation: the impact of blood pressure and diuretics. Transplant Proc (2010) 1.45
Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays. J Intern Med (2002) 1.42
Complement-mediated reactions to diazepam with Cremophor as solvent (Stesolid MR). Br J Anaesth (1980) 1.08
On the inhibitory effect of albumin on platelet aggregation. Thromb Res (1980) 1.06
Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells. Br J Pharmacol (2011) 1.01
Catalytic Enantioselective Addition of Nitro Compounds to Imines-A Simple Approach for the Synthesis of Optically Active β-Nitro-α-Amino Esters. Angew Chem Int Ed Engl (2001) 0.95
The effect of prednisone on platelet function tests. Scand J Haematol (1982) 0.94
A novel catalytic and highly enantioselective approach for the synthesis of optically active carbohydrate derivatives. J Org Chem (2000) 0.92
Acetylsalicylic acid, bleeding time and age. Thromb Res (1980) 0.91
Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment. Am J Physiol Renal Physiol (2006) 0.90
Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function. Eur J Clin Invest (1986) 0.89
Catalytic Asymmetric Direct Mannich Reactions of Carbonyl Compounds with α-Imino Esters. Angew Chem Int Ed Engl (2001) 0.88
Platelets and atherosclerosis. A review on the role of platelets in atherosclerosis with special reference to the role of polyunsaturated 20 carbon fatty acids. Dan Med Bull (1980) 0.87
Marine oils and thrombogenesis. Prog Lipid Res (1982) 0.87
Familial functional antithrombin III deficiency. Scand J Haematol (1980) 0.86
Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood. Thromb Res (1981) 0.86
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Ann Oncol (2011) 0.85
Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'. Thromb Res (1982) 0.84
Naloxone does not antagonize diazepam-induced sedation. Anesthesiology (1979) 0.84
Catalyhtic asymmetric Henry reactions--a simple approach to optically active beta-nitro alpha-hydroxy esters. Chem Commun (Camb) (2001) 0.84
Asymmetric catalysis of 1,3-dipolar cycloaddition reactions--the concepts of activation and induction of asymmetry. Sci Prog (1999) 0.82
Recurrent thrombosis in a patient with factor XII deficiency. Acta Haematol (1980) 0.82
Hydrocortisone inhibits platelet prostaglandin and endothelial prostacyclin production. Pharmacol Res Commun (1981) 0.82
Decreased blood platelet volume and count in patients with liver disease. Scand J Gastroenterol (1984) 0.82
Calcineurin activity in tacrolimus-treated renal transplant patients early after and 5 years after transplantation. Transplant Proc (2006) 0.81
Comparison of the pharmacokinetics of tacrolimus and cyclosporine at equivalent molecular doses. Transplant Proc (2003) 0.81
Amyl nitrite and Kaposi's sarcoma in homosexual men. N Engl J Med (1982) 0.80
Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients. Transplant Proc (2002) 0.80
Stability of prostacyclin in plasma. Lancet (1979) 0.80
Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients. Transplant Proc (2005) 0.80
Platelet aggregation is not essential for xenograft rejection. Thromb Res (1986) 0.80
Proximal glomerulo-tubular balance in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1984) 0.80
Platelet aggregation and release of ATP in patients with hepatic cirrhosis. Scand J Gastroenterol (1985) 0.80
Outpatient sputum cytology in the diagnosis of lung cancer. Scand J Respir Dis (1977) 0.79
Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation. Pharmacol Res Commun (1979) 0.79
Gene expression analysis of calcineurin isoforms in T-lymphocytes--a method applied on kidney-transplant recipients. Transpl Immunol (2010) 0.79
Antithrombin III and the nephrotic syndrome. Scand J Haematol (1979) 0.79
24-h monitoring of calcineurin phosphatase activity in healthy subjects. Scand J Immunol (2005) 0.79
Flush perfusion of rabbit kidneys with autogeneic, allogeneic and xenogeneic blood. Scand J Urol Nephrol (1991) 0.79
Prediction of spleen size by routine radioisotope scintigraphy. Acta Haematol (1983) 0.79
The complement system in uremia. Scand J Urol Nephrol (1980) 0.78
Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine A concentration. Clin Nephrol (1986) 0.78
Hemostatic factors and renin in Greenland Eskimos on a high eicosapentaenoic acid intake. Results of the Fifth UmanaK Expedition. Acta Med Scand (1986) 0.77
Aspirin and bleeding-time: dependency of age. Lancet (1979) 0.77
Heparin like activity of albumin. Thromb Res (1979) 0.77
The effect of arachidonic- and eicosapentaenoic acid on the synthesis of prostacyclin-like material in human umbilical vasculature. Artery (1980) 0.77
Xenoperfusion of rabbit kidney and the impact of BN 52021: a specific antagonist of platelet-activating factor. Transplant Proc (1990) 0.77
A biphasic effect of prostacyclin (PGI2) on platelet aggregation. Thromb Res (1980) 0.77
Human umbilical blood vessel converts all cis-5, 8, 11, 14, 17 eicosapentaenoic acid to prostaglandin I3. Prostaglandins (1981) 0.76
Etomidate infusion and adrenocortical function. A study in elective surgery. Acta Anaesthesiol Scand (1985) 0.76
Charcoal haemoperfusion and antidepressant overdose. Lancet (1978) 0.76
Development of anti-OKT3 antibodies after OKT3 treatment. Scand J Urol Nephrol (1996) 0.76
Heparin-free hypothermal hemodialysis at 20 degrees C improves biocompatibility. Blood Purif (1997) 0.76
[Hemoperfusion in deliberate drug poisoning. Review and 2 case reports]. Ugeskr Laeger (1978) 0.76
The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients. Diabet Med (2012) 0.76
EBV-induced post-transplant lymphoproliferative disorder (PTLD). Transplant Proc (1995) 0.76
Plasma histidine-rich glycoprotein and plasminogen in patients with liver disease. Thromb Res (1985) 0.75
Hydrocortisone, platelet aggregation and platelet prostaglandin metabolism. Scand J Haematol (1980) 0.75
Prostacyclin and haemolytic, thrombocytopenic microangiopathy. Lancet (1981) 0.75
Variable interpretation of early whole body bone scans in breast cancer patients. Dan Med Bull (1984) 0.75
Whole body bone scintigraphy compared to conventional radiography in detecting bone lesions in multiple myeloma. Dan Med Bull (1981) 0.75
Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis. Nephron (1979) 0.75
[Legionnaires' disease in Denmark imported from Italy]. Ugeskr Laeger (1979) 0.75
Studies on the biological balance between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction. Dan Med Bull (1982) 0.75
[A case of factor XI deficiency--hemophilia C]. Ugeskr Laeger (1979) 0.75
Antithrombin III in uremia. Scand J Urol Nephrol (1979) 0.75
Platelets and renal disease. A review. Dan Med Bull (1981) 0.75
Effect of glucocorticosteroids on some coagulation tests. Acta Haematol (1982) 0.75
[Acute epiglottitis complicated by Haemophilus influenzae type b meningitis]. Ugeskr Laeger (1988) 0.75
The destruction of N-nitrosamides with 2,4-bis(4-methoxyphenyl)-1,3,2,4-dithiodiphosphetane-2,4-disulfide. Attempts to nitrosate thioamides. IARC Sci Publ (1982) 0.75
Acetylsalicylic acid and bleeding time in juvenile diabetes mellitus. Thromb Res (1981) 0.75
Serum thymidine kinase in AIDS patients treated with zidovudine. Lancet (1987) 0.75
Antithrombin III and dietary intake of polyunsaturated fatty acids. Scand J Clin Lab Invest (1982) 0.75
Antithrombin III and platelets during the normal menstrual cycle and in women receiving oral contraceptives low in oestrogen. Gynecol Obstet Invest (1983) 0.75
[Nitrosation reagents (e.g. amyl nitrite) as possible cause of Kaposi's sarcoma in homosexual men]. Ugeskr Laeger (1982) 0.75
[Legionnaires' disease in Denmark]. Ugeskr Laeger (1979) 0.75
[Thrombocytosis. A review of 500 cases]. Ugeskr Laeger (1983) 0.75
[Reduction in thrombocyte volume and thrombocyte count in liver disease]. Ugeskr Laeger (1984) 0.75
[Hemolytic uremic syndrome. Treatment by plasma exchange]. Ugeskr Laeger (1981) 0.75
[Peripheral vascular occlusion as the primary symptom in essential thrombocytosis]. Ugeskr Laeger (1982) 0.75
Bone mineral content in myelomatosis. Acta Med Scand (1982) 0.75
The reaction of N-nitroso compounds with 2,4-bis (4-methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-disulfide. New aspects of the destruction of the N-nitroso function. IARC Sci Publ (1980) 0.75
Legionnaires' disease imported to Denmark from Italy. Scand J Infect Dis (1981) 0.75
[Alcoholic thrombocytopenia]. Ugeskr Laeger (1985) 0.75
Variable interpretation of liver scintigraphy in malignancy as an aid in clinical decision-making. Acta Med Scand (1982) 0.75
C3 polymorphism in Greenland Eskimos. Hum Hered (1982) 0.75
C3 polymorphism in patients with chronic uremia. Hum Hered (1980) 0.75